Home

distancia brumoso Engaño curr opin investig drugs apagado al revés estante

BIOLÓGICOS EN EL TRATAMIENTO DEL ASMA GRAVE EN PEDIATRÍA | Murua | Revista  de asma
BIOLÓGICOS EN EL TRATAMIENTO DEL ASMA GRAVE EN PEDIATRÍA | Murua | Revista de asma

Classification of Metal-Based Drugs according to Their Mechanisms of Action  - ScienceDirect
Classification of Metal-Based Drugs according to Their Mechanisms of Action - ScienceDirect

BIOLOGÍA FEROMONAL EN LA ESPECIE HUMANA
BIOLOGÍA FEROMONAL EN LA ESPECIE HUMANA

PDF) Investigational drugs for hyperuricemia
PDF) Investigational drugs for hyperuricemia

Targeting silibinin in the antiproliferative pathway
Targeting silibinin in the antiproliferative pathway

PDF) COMMERCIALIZATION OF GENE THERAPY DRUGS | Muhammad Irfan-Maqsood and  Muhammad Aslamkhan - Academia.edu
PDF) COMMERCIALIZATION OF GENE THERAPY DRUGS | Muhammad Irfan-Maqsood and Muhammad Aslamkhan - Academia.edu

Oleuropein-Induced Acceleration of Cytochrome P450–Catalyzed Drug  Metabolism: Central Role for Nuclear Receptor Peroxisome  Proliferator-Activated Receptor α | Drug Metabolism & Disposition
Oleuropein-Induced Acceleration of Cytochrome P450–Catalyzed Drug Metabolism: Central Role for Nuclear Receptor Peroxisome Proliferator-Activated Receptor α | Drug Metabolism & Disposition

Reducing the Cost of Treating Obstructive Sleep Apnea
Reducing the Cost of Treating Obstructive Sleep Apnea

IJMS | Free Full-Text | Lessons on Drug Development: A Literature Review of  Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials
IJMS | Free Full-Text | Lessons on Drug Development: A Literature Review of Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials

IJMS | Free Full-Text | Drug Development and the Use of Induced Pluripotent  Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity  Screening
IJMS | Free Full-Text | Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening

Development of WF10, a novel macrophage-regulating agent.
Development of WF10, a novel macrophage-regulating agent.

Current Opinion in Investigational Drugs
Current Opinion in Investigational Drugs

Nanoparticle-Based Drugs and Formulations: Current Status and Emerging  Applications | ACS Applied Nano Materials
Nanoparticle-Based Drugs and Formulations: Current Status and Emerging Applications | ACS Applied Nano Materials

Adding sarcosine, but not D-serine, to risperidone improves symptoms in  people with acute phase schizophrenia
Adding sarcosine, but not D-serine, to risperidone improves symptoms in people with acute phase schizophrenia

Etidronate
Etidronate

Asparaginase(USAN)
Asparaginase(USAN)

Surrogate Endpoints in Infectious Diseases Trials: FDA Perspective  Surrogate Endpoints in Infectious Diseases Trials: FDA Perspective John H.  Powers, MD. - ppt download
Surrogate Endpoints in Infectious Diseases Trials: FDA Perspective Surrogate Endpoints in Infectious Diseases Trials: FDA Perspective John H. Powers, MD. - ppt download

Current and emerging avenues for Alzheimer's disease drug targets -  Loera‐Valencia - 2019 - Journal of Internal Medicine - Wiley Online Library
Current and emerging avenues for Alzheimer's disease drug targets - Loera‐Valencia - 2019 - Journal of Internal Medicine - Wiley Online Library

Poster Sessions
Poster Sessions

PDF) Celgosivir, an ??-glucosidase I inhibitor for the potential treatment  of HCV infection
PDF) Celgosivir, an ??-glucosidase I inhibitor for the potential treatment of HCV infection

JP2013507135A - Manipulation of osmolality to differentiate stem cells -  Google Patents
JP2013507135A - Manipulation of osmolality to differentiate stem cells - Google Patents

Expert Opinion on Investigational Drugs: Vol 32, No 4 (Current issue)
Expert Opinion on Investigational Drugs: Vol 32, No 4 (Current issue)

Metabolic drug survey highlights cancer cell dependencies and  vulnerabilities | Nature Communications
Metabolic drug survey highlights cancer cell dependencies and vulnerabilities | Nature Communications

Current Opinion in Investigational Drugs
Current Opinion in Investigational Drugs

Investigational Drugs
Investigational Drugs